Genomic variation in macrophage-cultured European porcine reproductive and respiratory syndrome virus Olot/91 revealed using ultra-deep next generation sequencing

被引:13
|
作者
Lu, Zen H. [1 ,2 ]
Brown, Alexander [1 ,2 ]
Wilson, Alison D. [1 ,2 ]
Calvert, Jay G. [3 ]
Balasch, Monica [4 ]
Fuentes-Utrilla, Pablo [5 ]
Loecherbach, Julia [5 ]
Turner, Frances [5 ]
Talbot, Richard [5 ]
Archibald, Alan L. [1 ,2 ]
Ait-Ali, Tahar [1 ,2 ]
机构
[1] Univ Edinburgh, Roslin Inst, Edinburgh EH25 9RG, Midlothian, Scotland
[2] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH25 9RG, Midlothian, Scotland
[3] Zoetis Inc, Global Biol Res, Kalamazoo, MI 49007 USA
[4] VMRD Olot Zoetis, Vall De Bianya 17813, Girona, Spain
[5] Univ Edinburgh, Edinburgh EH25 9RG, Midlothian, Scotland
来源
VIROLOGY JOURNAL | 2014年 / 11卷
基金
英国生物技术与生命科学研究理事会;
关键词
PRRSV; Microevolution; Variant spectra; Ultra-deep next generation sequencing; T-CELL EPITOPES; PROTEINS;
D O I
10.1186/1743-422X-11-42
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Porcine Reproductive and Respiratory Syndrome (PRRS) is a disease of major economic impact worldwide. The etiologic agent of this disease is the PRRS virus (PRRSV). Increasing evidence suggest that microevolution within a coexisting quasispecies population can give rise to high sequence heterogeneity in PRRSV. Findings: We developed a pipeline based on the ultra-deep next generation sequencing approach to first construct the complete genome of a European PRRSV, strain Olot/9, cultured on macrophages and then capture the rare variants representative of the mixed quasispecies population. Olot/91 differs from the reference Lelystad strain by about 5% and a total of 88 variants, with frequencies as low as 1%, were detected in the mixed population. These variants included 16 non-synonymous variants concentrated in the genes encoding structural and nonstructural proteins; including Glycoprotein 2a and 5. Conclusion: Using an ultra-deep sequencing methodology, the complete genome of Olot/91 was constructed without any prior knowledge of the sequence. Rare variants that constitute minor fractions of the heterogeneous PRRSV population could successfully be detected to allow further exploration of microevolutionary events.
引用
收藏
页数:5
相关论文
共 6 条
  • [1] Genomic variation in macrophage-cultured European porcine reproductive and respiratory syndrome virus Olot/91 revealed using ultra-deep next generation sequencing
    Zen H Lu
    Alexander Brown
    Alison D Wilson
    Jay G Calvert
    Monica Balasch
    Pablo Fuentes-Utrilla
    Julia Loecherbach
    Frances Turner
    Richard Talbot
    Alan L Archibald
    Tahar Ait-Ali
    Virology Journal, 11
  • [2] Genomic Evolution of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Isolates Revealed by Deep Sequencing
    Brar, Manreetpal Singh
    Shi, Mang
    Hui, Raymond Kin-Hi
    Leung, Frederick Chi-Ching
    PLOS ONE, 2014, 9 (04):
  • [3] Next-generation sequencing as a tool for the study of Porcine reproductive and respiratory syndrome virus (PRRSV) macro- and micro-molecular epidemiology
    Cortey, M.
    Diaz, I.
    Martin-Valls, G. E.
    Mateu, E.
    VETERINARY MICROBIOLOGY, 2017, 209 : 5 - 12
  • [4] High-throughput whole genome sequencing of Porcine reproductive and respiratory syndrome virus from cell culture materials and clinical specimens using next-generation sequencing technology
    Zhang, Jianqiang
    Zheng, Ying
    Xia, Xiao-Qin
    Chen, Qi
    Bade, Sarah A.
    Yoon, Kyoung-Jin
    Harmon, Karen M.
    Gauger, Phillip C.
    Main, Rodger G.
    Li, Ganwu
    JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION, 2017, 29 (01) : 41 - 50
  • [5] Genomic profiling using targeted ultra-deep next-generation sequencing for prediction of treatment outcome after concurrent chemoradiation of locally advanced head and neck cancer
    Tinhofer, I
    Budach, V
    Stenzinger, A.
    Weichert, W.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 118 - 118
  • [6] Genomic profiling using targeted ultra-deep next-generation sequencing for prediction of treatment outcome after concurrent chemoradiation: Results from the German ARO-0401 trial.
    Tinhofer, Inge
    Budach, Volker
    Endris, Volker
    Stenzinger, Albrecht
    Weichert, Wilko
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)